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SUMMARY
Within the immune system an important lineage commitment decision faced by 
the haemopoietic progenitor cells (HPCs) is whether to adopt a T or B 
lymphocyte fate. Recent studies have indicated that Notch, a transmembrane 
receptor, plays a crucial role in inducing HPCs to adopt a T cell fate. Similarly 
transcription factors E2A, early B cell factor and Pax5 have been shown to be 
important in the generation of B lymphocytes from HPCs. Many of the upstream 
signalling pathways that regulate the expression and activation of these 
transcription factors remain largely undefined.
To generate T cells from HPCs in vitro, we utilised foetal thymic organ culture 
(FTOC), high oxygen submersion FTOC techniques and the novel system 0P9- 
DL1 a bone marrow stromal cell line expressing the Notch ligand Delta-like-1. 
HPCs, retrovirally infected with constitutively active Ras mutants, were cultured 
in each of the afore mentioned in vitro culture systems. Results indicate that 
constitutive activation of the Ras-mediated signalling pathways, by retrovi rail y 
infected cells with constitutively active Ras^^^, results in HPCs adopting a B cell 
fate within a T cell microenvironment. Furthermore, constitutive Ras-extracellular 
signal-regulated kinase (ERK)-mitogen-activated protein kinase (MAPK) 
signalling may be key in promoting B cell fate within these systems as 
Ras^^^S35, which leads to a constitutive activation of Raf binding in the absence 
of PI3K binding, results in the adoption of a B cell fate. By contrast Ras^^^C40, 
which binds PI3K but not Raf, led to normal T cell fate adoption. Importantly, we 
have also shown in vivo that retrovirally infected HPCs adoptively transferred into 
neonatal recombination activating gene-1 deficient mice resulted in Ras/ERK- 
MAPK dependent B cell commitment within the thymus. These results suggest 
that constitutive Ras signals antagonise Notch-1 to promote B cell fate at the 
expense of T cell development.
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CHAPTER 1 -  Introduction 
1.1 Immune System
The main function of the immune system is to protect the host from infectious 
microbes in the environment. Environmental pathogens threaten the host with 
various pathogenic mechanisms, therefore the immune response uses a complex 
array of protective mechanisms to control and usually eliminate these organisms. 
All of these mechanisms rely on detecting structural features of the pathogens that 
mark them as distinct from the host, so as to eliminate the pathogen without 
excessive damage to its own tissue.
There are two main classes of host recognition:
♦ Innate immunity which serves as a first line defence and includes all 
defence mechanisms that are encoded in the germline genes of the host, 
i.e., epithelial barriers and mucocoliary barriers.
♦ Adaptive immunity is based on clonal selection of antigen-specific 
receptors expressed on the surface of T and B lymphocytes enabling the 
host immune system to recognise any foreign antigen. The antigen- 
specific receptors of the adaptive response are assembled by means of 
somatic rearrangement of germline gene elements to form intact T cell 
receptor (TCR) and immunoglobulin (Ig) genes (1 ). The assembly of 
antigen receptors from a collection of a few hundred germline-encoded 
gene elements permits the formation of millions of different antigen 
receptors, each with the potentially unique specificity for a different 
antigen (2).
Although the innate and adaptive immune responses are fundamentally different in 
their mechanisms of action, synergy between them is essential for an intact and 
fully effective immune response.
1.2 Lymphocyte lineage Commitment
1.2.1 Haemopoiesis
The development of the various haemopoietic cell lineages are compartmentalised 
during foetal development and throughout adult life. Approximately by day 9 of 
embryonic development the foetal liver (FL) is seeded by definitive haemopoietic 
progenitor cells (HPCs), the FL continues as the primary site of haemopoietic 
development until birth, when the bone marrow (BM) takes over as the primary site 
in adults. Stem cell differentiation is regulated by soluble factors and cell contact 
dependent signals within specialised microenvironments, each of which supports 
the development of specific cell lineages.
Pluripotent HPCs in the FL and BM, have an extensive self-renewal potential 
regenerating all blood cell types throughout life by differentiating to multipotent 
progenitor cells (MPP), which have gradually restricted developmental potential. 
MPPs commit to either the lymphoid or erythro-myeloid lineages, giving rise to 
common lymphoid (CLP) or common myeloid (CMP) progenitors (3-5). The loss of 
long term self-renewal capacities in MPPs is accompanied by the expression of the 
tyrosine kinase receptor Flt3 (6). The early HPC cell is thought to give rise to the 
recently identified early T-lineage progenitor (ETP) in the thymus and to the HPC in 
the bone marrow, which is able to develop into four cell types: B, T, natural killer 
cells (NK) and dendritic cells (DC) (7).
The development of B and T lymphocytes, from HPCs is a multistep process that 
involves the ordered expression of a large number of genes. It is clear that the 
antigen receptors play essential roles not only in transducing signals for B and T 
cell activation and regulation of the immune response, but also in transducing 
signals required for development and continued survival.
HPCs with T cell potential leave the FL or BM and migrate to the thymus where 
they undergo a tightly regulated developmental programme involving proliferation,
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differentiation and selection to produce a functionally diverse population of T cells. 
Although, many of the phenotypic changes associated with specification and 
commitment to the T cell lineage are well characterised, the signals that drive 
these events are less clear. On the other hand, B cell development takes place 
within the BM microenvironment. Commitment of HPCs to B cell lineage is 
dependent on the expression of the paired box transcription factor Pax5, which 
acts to promote the expression of B cell lineage genes while suppressing genes 
responsible for T cell, erythroid or myeloid cell development (8). Once committed,
B cell precursors pass through a number of developmental stages marked by a 
series of changes in location and in the expression of genes, intracellular signalling 
proteins and cell surface markers.
1.2.2 Lineage choice of HPCs
The primary lineage choice that developing lymphocytes undergo is commitment to 
either the B or T cell lineage. Notch receptors and their corresponding ligands 
comprise of a family of evolutionary conserved trans-membrane proteins initially 
described in Drosophila, and found in organisms as diverse as worms and 
humans. Thus far, mammals possess four Notch receptors (Notch 1-4) and five 
ligands, Jagged 1 and 2, and Deltal, 3 and 4. Notch receptors are synthesised, as 
precursor proteins that are cleaved during transport to the cell surface and are 
expressed as heterodimers. Ligand binding to the extracellular domain initiates a 
cascade of proteolytic cleavages ultimately releasing the cytoplasmic domain of the 
Notch receptor, which translocates to the nucleus and binds to the transcription 
factor recombination binding protein-J (RBP-J). The binding of Notch cytoplasmic 
domain to RBP-J converts it from a transcriptional repressor into a transcriptional 
activator that leads to the activation of Notch target genes. Modulators, acting at 
the extracellular, cytoplasmic and nuclear levels, can regulate notch signalling.
During haemopoiesis, the T versus B lineage decision depends on Notch 1 for the 
development of both thymus-dependent and thymus-independent T cells (9-11) 
(Figure 1.1). It has been shown by Pui e t a i, (12) that B cell development is
abolished in mice that are reconstituted with BM-HPCs expressing a constitutively 
active form of Notch, and that CD4^CD8^ double positive (DP) T cells develop in 
the BM of these mice. In a complementary experiment Notch 1 deficient mice 
displayed a severe block in T cell development, with the simultaneous 
development of B cells in the thymus; thus implying that Notch signalling is crucial 
for the earliest stages of T cell commitment, and that Notch 1 signalling must be 
either absent or negatively regulated in BM progenitor cells to allow B cell 
development, and that the Notch 1 signal is sufficient for T cell commitment (13,
14).
The question that then arises is ‘how do B cells still develop in the BM 
compartment despite the fact that Notch receptors and ligands are expressed on 
BM progenitors and stroma?’ Among the family of Notch receptors it is 
predominantly Notch2 that is expressed in B cells, the level of Notch2 expression 
increases with B cell maturation and is prominent in splenic B cells, indicating a 
role in mature B cells (15). It has been shown by Souabni e t at (16) that the B 
lineage commitment factor Pax5 represses the transcription of the Notch 1 gene. B 
cell commitment depends on the transcription factors E2A, early B cell factor (EBF) 
and Pax5. E2A and EBF activate the expression of B cell specific genes, which 
are essential for the generation of the earliest B cell progenitors. However, the 
activation of the B cell specific transcription programme is not sufficient to commit 
early progenitors in the absence of the Pax5 expression. The absence of Pax5 
arrests B cell development at an early pro-B cell stage, even in the presence of 
other specific transcription programmes. Subsequently the restoration of Pax5 in 
Pax5'^‘ pro-B cells can promote development to mature B cells (17). Whether 
Notch 1 plays a similar role in T cell progenitors by repressing Pax5 expression 
remains to be seen. Therefore in an effort to understand the signalling 
mechanisms that control this lineage commitment decision, we will manipulate 
HPCs with signalling mutants, and utilising in vitro T cell generation systems 
(FTOC, HOS-FTOC and 0P9-DL1) to investigate how these molecules impact B 
and T lineage cell fate decisions.
1.3 T Cell Development
T cell development occurs In the thymus where the unique processes of T cell 
differentiation and repertoire selection are induced by the specialised cellular 
microenvironments provided by the thymic stroma (18). This comprises an ordered 
three dimensional network of epithelial cells interspersed with non-epithelial 
stromal cells. It is broadly divided into two compartments, the cortex and the 
medulla, each of which contain several epithelial cell types (Figure 1.2) (19). 
However, lineage relationships between the thymic epithelial subpopulations and 
the molecular mechanisms behind their functional differences are poorly 
understood. Early thymus organogenesis occurs between day 9.5 and 11.5 of 
murine embryonic development, and results in the development from the third 
pharyngeal pouch of a common primordium containing prospective thymus and 
parathyroid domains (20, 21). The thymus and parathyroid primordia separate by 
day 12.5, by which time the thymic epithelial rudiment is encapsulated by the 
mesenchyme. Mesenchyme derived signals are required to support thymic 
development. HPCs colonise the thymus from day 11.5, and during organogenesis 
interactions between thymocytes and thymic epithelial cells are required to 
establish proper organisation and function of the cortical and medullary 
compartments (19, 20). The nu/nu phenotype (nude) of congenital athymia is 
caused by mutation of the transcription factor Foxn1 (whn), while not involved in 
the initiation of thymic organogenesis, it has been shown to be required for the 
development of all major thymic epithelial subpopulations (22). Deficiency in Whn 
results in a cystic thymic rudiment in adults and consequently causes a marked 
reduction of T cells, with some cells still being generated extrathymically (20).
Early T cell progenitors undergo a number of differentiation steps that are typically 
defined by the cell surface expression of CD4 and CD8. HPCs entering the 
thymus at day 11.5, from the FL or BM, lack expression of CD4 or CD8 and are 
hence termed double negative (DN) thymocytes (23). They then become 
CD4^CD8^ double positive (DP) thymocytes, and lastly mature into single positive 
(SP) CD4'*' or CD8^ T cells (20) (Figure 1.3). DN thymocytes can be further
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characterised by the ordered expression of two cell surface molecules CD117 
(stem cell factor receptor) and CD25 (IL-2 receptor alpha): CD117‘*'CD25’ (DNI); 
CD117^CD25^ (DNII); CD117 CD25'^ (DNIll); CD117"CD25" (DNIV) (24) (Figure 
1.3). DNls still have multi-lineage potential (including T/B/NK/dendritic cell (DC)), 
DNI Is have lost their ability to give rise to B cells but can give rise to T and NK 
cells, whereas DNII Is are fully committed to T cell lineage with no B cell potential 
(13).
The specificity of the adaptive immune response is partly dependent on the clonal 
expression of the mature TCR on lymphocytes. The expression of a newly 
rearranged TCRp chain with a pre-Ta and CD3 complex on DNIll cells, to form the 
pre-TCR complex, represents a critical checkpoint in T cell differentiation known as 
(3 selection (25). The pre-TCR complex triggers a maturation programme within 
developing thymocytes that includes: rescue from apoptosis; inhibition of further 
DNA recombination at the TCRp gene locus (allelic exclusion) (26); proliferation; 
down-regulation of CD25; up-regulation of CD4/CD8 and inhibition of TCRa gene 
rearrangement. The second checkpoint occurs when DP thymocytes undergo 
positive and negative selection, which enables the differentiation of MHC-restrictive 
and self-tolerant CD4^ or CD8^ SP a[3 T cells (23).
1.3.1 Pre-TCR complex
The TCR(3 chain couples to the pre-Ta chain, which together with the CD3 
molecules (s, y, 5, and Q form the pre-TCR complex. The pre-TCR complex drives 
the generation of DP cells by signal transduction through the CD3 complex. The 
activation of the pre-TCR does not appear to depend on ligand engagement (unlike 
most lymphocyte surface receptor complexes), in fact ligand engagement of the 
pre-TCR in vivo arrests maturation of the thymocyte prior to the DP stage (23).
The potential ligand binding exodomains of pTa and TCRp have been shown to be 
dispensable for pre-TCR function (27), suggesting that engagement by a specific 
ligand is not responsible for initiation of pre-TCR signalling in vivo. Therefore, it is
thought that the pre-TCR needs to be transported to the cell surface of immature 
thymocytes to be in situ to meet crucial signalling components. It would therefore 
appear that the pre-TCR has a unique ability to transduce p-selection signals even 
when expressed at low levels and when not engaged by a surface receptor. There 
are several hypotheses to explain this phenomenon, all of which suggest that the 
pre-TCR complex signals constitutively (27). The lack of specific ligand recognition 
could be explained by the recent findings which show that the pre-TCR complex 
(directed by the presence of the palmitoyl moiety on the pTa chain) has the ability 
to spontaneously target the distinct lipid microenvironments (lipid rafts) in the 
plasma membrane of pre-T cells. The lipid rafts provide a framework for signalling 
protein complexes and therefore provide a platform for the initiation of downstream 
signalling cascades, which compensates for the requirement of ligand binding.
This is in direct contrast to the TCRa(3 complex, where ligand binding by the 
antigen receptor is absolutely essential for the further differentiation of DP 
thymocytes and activation of mature T cells.
Another finding that has helped to explain how the pre-TCR complex has such a 
high signal efficiency in the absence of ligand recognition, is the activation 
threshold of pre-T cells (23). Pre-T cells have a high expression of activation 
marker CD25, possibly implicating that they are in a heightened activation state, 
therefore it is thought that pre-T cells may have a lower threshold of activation (28). 
Therefore the pre-T cell may provide a unique environment that is poised to 
respond to differentiation signals upon generation of a functionally rearranged 
TCRp chain.
1.3.2 Downstream signalling events of the pre-TCR complex
Due to the structural similarity between the pre-TCR and the mature TCR complex, 
and the reliance of both receptors on the immunoreceptor tyrosine-based activation 
motifs (ITAMs) containing CD3 moieties to transmit signals from the cell surface to 
the nucleus, it is thought that the signalling properties of both receptors may be 
similar (29). Upon pre-TCR formation, Lck phosphorylates tyrosines within the 
ITAMs of the TCRÇ resulting in the recruitment of ZAP-70 (zeta associated protein, 
70 kD) to the pre-TCR complex. In return ZAP-70 phosphorylates the adaptor 
molecules LAT (linker for activation of T cells) and SLP-76 (SH2 domain-containing 
leukocyte protein, 76 kD). SLP-76 is responsible for the coupling of TCRap with 
phospoholipase C-y1 (PLCy1), and Ras mediated signalling pathways which result 
in downstream signalling events such as: Ca^^ mobilization; protein kinase C 
(PKC) activation; and extracellular signal regulated kinase-mitogen-activated 
protein kinases (ERK-MAPK) activation (30-32). Such signalling events are 
essential for the activation of T cell effector function. The notion that the active 
Ras/Raf signalling cascade plays a central role during p selection is supported by 
data obtained from mice bearing targeted genetic deficiencies or mutations of key 
signalling molecules such as Lck, LAT or SLP-76, also showing the importance of 
these molecules in pre-TCR signalling (33-35). These mice display a block in T 
cell development at the DN stage, implying that these molecules are essential for 
differentiation to the DP stage of development. The importance of PKC activation 
during p selection has been shown by Michie et ai (36), SLP-76 is responsible for 
binding to and activating PLCy which in turn activated PKC. Michie et ai introduced 
a retroviral construct encoding a dominant negative PKCa into developing 
thymocytes, which resulted in a block in the generation of DP thymocytes. The 
molecules involved during the initial activation steps that mediate p selection are 
outlined in Figure 1.4.
Further insights into which signalling molecules are important for the p selection 
checkpoint have been gained by the introduction of transgenes encoding activated 
signalling components into recombination activating gene-1 or-2-deficient (RAG" '^)
mice (37). These mice are halted at the DNIll stage of T cell development due to 
an inability to initiate antigen receptor rearrangement. When productively 
rearranged TCRp transgenes were introduced into RAG'^" mice they allowed the 
further differentiation of DN cells, indicating that a functional TCRp chain is 
sufficient for progression to the DP stage. Moreover, RAG‘ ‘^ mice containing a 
transgene encoding constitutively active GTPase Ras (Ras^^^) display cellular 
proliferation and generation of DP cells by bypassing the pre-TCR dependent p 
selection processes (38). This suggests that Ras is involved in promoting p 
selection, by activating the ERK-MAPK cascade. Although it can be shown that 
ERK-MAPK can mediate proliferation and differentiation of DN thymocytes, 
Crompton et al has shown by the introduction of constitutively active MAPK kinase- 
1 (MEK1) into developing thymocytes from RAG"‘^‘ mice only resulted in the 
generation of immature single positive thymocytes (39). Therefore suggesting that 
additional signals upstream of MEK1 may be responsible for full differentiation of 
DN thymocytes to the DP stage. Michie et a! (40) have developed a novel 
experimental system which allows the introduction of ELK-1-reporter-plasmids into 
thymic lobes, using gene gun-mediated transfection. This system facilitated the 
study of specific biochemical signalling events that ensure upon the formation of 
the pre-TCR complex. Using this system they have been able to show that the 
ERK signalling cascade was activated in developing thymocytes as a result of pre- 
TCR complex formation in vivo (41 ).
1.4 B Cell Development
The processes controlling B cell development are tightly regulated to ensure a
constant supply of B cells expressing Ag receptors of distinct specificity, which
enables identification of any already encountered Ag, yet simultaneously avoiding
the generation of auto-reactive B cells that recognise ‘self Ags. This complex
process involves the integration of numerous signals at a number of stages,
including Ag, soluble mediators and accessory cells. Once committed, the pre B
cells pass through a number of development stages marked by a series of changes
in location and in the expression of genes, intracellular signalling proteins and cell
9
surface markers. B cell development can be broadly divided into two quite distinct 
phases; Ag-independent and Ag-dependent (42). The Ag-independent phase 
occurs in the BM and involves the production of a repertoire of immature B cells 
bearing functional Ag receptors. During this process of receptor editing an 
encounter with Ag leads to death by apoptosis, or anergy, a process by which the 
B cell becomes unresponsive to future encounters with its particular Ag. B cells 
that emerge into the periphery are termed immature B cells, and these migrate to 
the secondary lymphoid organs, such as the spleen and lymph nodes (LNs). At 
the periphery, B cell recognition of Ag (in association with specialised Ag- 
presenting cells and stromal cells) can lead to one of several developmental 
pathways in the production of mature B cells from transitional B cells: anergy 
and/or apoptosis; activation, proliferation and differentiation into high rate Ab 
secreting plasma cells; or differentiation into memory B cells (43).
The earliest marker that defines cells committed to the B cell lineage is the CD45R 
isoform B220, a membrane tyrosine phosphatase (Figure 1.5). B220 and GDI 9 
are expressed through out B cell development, with levels increasing during the 
transition from the immature to the mature stage, which exhibit an increased BCR 
expression. At the late pro-B cell stage GD117 expression is lost, while GD24 
(HSA) is upregulated. Immature cells are characterised by the expression of 
membrane IgM (mIgM), which is required for the continual survival of mature B 
cells as they migrate to the periphery where they become resting mature B cells. 
An additional hallmark of B cell development is the ordered expression of 
surrogate, and ultimately mature, BGRs (44).
Competent BCR complexes promote positive selection and migration of B cells 
from the BM to the peripheral lymphoid organs, including spleen, and gut- 
associated lymphoid tissues. It is at these secondary sites, that B cells stimulated 
by antigens generate memory B cells and plasma cells which secret antibodies at 
the terminal stages of B cell development. The early stages of B cell development 
are characterised by the expression of transcriptional regulatory proteins, which
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can both activate or repress genes (45). Transcription factors including PU.1, E2A 
and EBF are essential for the earliest B lymphocyte developmental stages (46).
1.4.1 PU.1 and B cell lineage commitment
PU.1 transcription factor is an important regulator of HPC cell commitment and of B 
cell transcription factors. It has been reported that independently generated mouse 
lines with targeted deletions of PU.1 genes completely lack B cells, T cells and 
myeloid cells. Some studies reported B220* cells present that lack Ig heavy chain 
rearrangements (47-49). As a result of these findings it has been hypothesised 
that PU.1 may control the commencement of B cell development, DeKoter et al 
have shown that PU.1-deficient progenitors drives lineage determination in a dose- 
dependent manner, with low expression favouring the generation of B cells (50). 
The generation of B cells is indicated by the activation of B lineage specific genes, 
such as mb-1 (Ig-a); B29 (lg-|3); VpreB and X5 surrogate light chain components of 
the pre-BCR; RAG-1 and RAG-2; ebfl (which encodes EBF) and interleukin-7 
receptor a (IL-7Ra) (51). This data suggests that although PU.1 is essential for the 
generation of B cells, it does so only at low concentrations. In support of these 
findings Zou et a! have shown that the knockdown of PU.1 by small interfering (si) 
RNA’s in CD34^ haemopoietic progenitors promoted B lineage development at the 
expense of another lineage (52). The knockdown of PU.1 up-regulated the 
expression of IL-7Ra, EBF and Pax5 essential for B cell lineage commitment.
1.4.2 E2A, EBF and B cell commitment
B cell fate is characterised by the expression of genes encoding components of the 
B cell antigen receptor and rearrangement of the Ig heavy chain locus (53, 54).
The transcription factors E2A and EBF are essential for the determination of the B 
cell fate. The E2A gene encodes two basic helix-loop-helix proteins (E l2 and E47) 
generated by differential splicing, whose activities are induced during B cell 
development. EBF is an atypical helix-loop-helix zinc finger protein that expressed 
exclusively in the B lineage within the haemopoietic system (55, 56). It has been
11
shown that the targeted interference of E2A or EBF gene results in a block in the B 
cell development prior to the onset of early B lineage gene expression and the 
initiation of D-J rearrangements (56-59). Supporting this hypothesis Romanow et 
al have demonstrated that either E2A or EBF can induce specific D-Jh 
rearrangements in non-lymphoid cells when ectopically expressed with the RAG-1 
and RAG-2 genes.
1.4.3 Lineage Commitment by Pax5
The activation of B cell specific genes and V(D)J recombination by E2A and EBF 
alone is not sufficient to commit FIFOs to the B cell lymphoid lineage in the 
absence of Pax5 (60). It has been shown that Pax5 is the critical B lineage 
commitment factor that restricts the developmental options of early progenitors to 
the B cell pathway. Nutt et al have demonstrated that Pax5“^ ' pro-B cells still retain 
a broad lympho-myeloid potential, characteristic of uncommitted progenitors, due 
to their ability to differentiate in vitro into functional NK cells, DCs, macrophages, 
osteoclasts, and granulocytes, upon IL-7 withdrawal and appropriate cytokine 
stimulation (17, 61, 62). Flowever, this multilineage potential is suppressed by 
retroviral restoration of Pax5 expression, which promoted development to the 
mature B cell stage (58).
Pax5 plays a dual role during lineage commitment, by repressing inappropriate 
lineage genes and also simultaneously activating B cell specific genes, leading to 
the initiation of the B-lymphoid gene expression programme (17). Pax5 represses 
macrophage colony stimulating factor receptor (M-CSFR) and Notch 1 genes in 
committed B lymphocytes ensuring that these cells no longer respond to the 
myeloid cytokine M-CSF or to T cell inducing Notch 1 ligands (16, 17). Activated 
Pax5 target genes also code for essential components of the pre-BCR signalling 
pathway, including the receptor signalling chain iga (mb-1), the stimulatory co­
receptor GDI9 and the central adaptor protein BLNK (61, 63-66).
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1.4.4 Pre-BCR complex
The pre-BCR is composed of the IgH chain and the surrogate light chain encoded 
by VpreB and lambda 5. The pre-BCR has been implicated in precursor B cell 
proliferation, differentiation and IgH chain allelic exclusion (67). As with the BCR 
complex of immature and mature B cells, the Ig of the pre-BCR complex couples to 
the signal transduction molecules Iga and lg(3. These are first expressed on the 
surface of late pro-B cells in association with the integral membrane protein and 
molecular chaperone calnexin, which are required for pre-BCR signal transduction 
(44). Unlike the immature and mature B cell receptor there has been no antigen 
identified for the pre-BCR. However, it has been proposed that ligand independent 
basal signals generated through the ITAMs of Iga and Igp are sufficient to promote 
the development of pro-B cells into pre-B cells (68, 69), or that a BM stromal factor 
such as galectin-1 may bind to and activate the pre-BCR (70). Alternatively, it has 
been suggested by Ohnishi et al that the induction of signals be the pre-BCR 
involves the ligand independent aggregation of components of the pre-BCR (71).
Successful rearrangement of IgH gene locus, and subsequent expression of this 
chain as a functional pre-BCR complex, is fundamental for the development of pre- 
B cells. The pre-BCR initiates critical signals essential for the survival and 
proliferation of the developing B cell, such as the Erk-MAPK cascade (72). It is 
thought that the pre-BCR complex uses similar intracellular signalling molecules as 
the BCR complex, such as the protein tyrosine kinase Btk (Brunton’s tyrosine 
kinase) which is essential for optimal pre-BCR signalling and if deficient results in 
impaired B cell development at the pre-B cell stage (73). Furthermore, it has been 
shown that mice deficient in the tyrosine kinase Syk have impaired pre-BCR 
signalling leading to a disruption in the B cell development at the pro-B to pre-B cell 
transition. IL-7 is a survival factor for the pro-B cells due to its ability to activate Erk 
(74, 75). Thus, signals activated downstream of the pre-BCR promote survival and 
proliferation of the pre-B cells, therefore cells that are unable to rearrange genes 
encoding Ig heavy chain, and express a functional pre-BCR, do not undergo 
proliferation and are blocked at this stage of development.
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1.5 Involvement of Ras signalling in lymphocyte development
The G protein Ras (small GTPase) is a regulatory GTP hydrolase that cycles 
between two conformations: activated (Ras-GTP) or inactivated (Ras-GDP) (76, 
77). It is activated by guanine exchange factors (GEFs), which are themselves 
activated by mitogenic signals through feedback from the Ras itself. It is 
inactivated by GTPases-activating proteins (GAPs), which increase the rate of GTP 
hydrolysis, returning Ras to its GDP-bound form, while simultaneously releasing an 
inorganic phosphate. Ras is attached to the cell membrane by prénylation, is a key 
component in many pathways which couple growth factor receptors to downstream 
mitogenic effectors involved in cell proliferation or differentiation (78). Ras 
activates a number of pathways (Figure 1.6) but an especially important one 
seems to be the MAPKs, which themselves transmit signals downstream to other 
protein kinases and gene regulatory proteins (79).
1.5.1 The Ras-MAPK pathway
MAPKs are activated by a wide range of extracellular stimuli mediating an array of 
cellular functions, from proliferation and activation to growth arrest and cell death. 
The MAPK family is subdivided into three groups; the classical signal-regulated 
kinases (ERK-MAPK), the c-Jun N-terminal kinases, also known as the stress 
activated protein kinases (JNK/SAPK) and the p38 MAPKs (80). Activation of each 
group is determined by distinct upstream MAPK kinases (MEKs) and MAPKK 
kinases (MEKK). MAPKs are activated by dual phosphorylation on tyrosine and 
threonine residues, located in a T-X-Y motif, where the X is individual to each sub­
class of kinase. Following MAPK activation a number of downstream transcription 
factors are activated such as ELK-1 and c-myc (ERKMAPK); c-Jun, ATF-2 and p38 
(JNK); and ATF-2 and MAX (p38 MAPK). Therefore, phosphorylation and 
activation of these transcriptional regulators enables the MAPK families to regulate 
gene expression and hence, cellular responses.
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Activated Ras functions as an adaptor that binds with high affinity to Raf kinases 
and causes their translocation to the cell membrane, where full activation occurs. 
The exact mechanism behind this is not known, however it requires Ras binding 
and multiple phosphorylations including autophosphorylation at threonine 372 in 
the conserved region 2 domain (81). Activated Raf then binds to and 
phosphorylates the dual specificity kinases MEK1/2, which in turn phosphorylates 
ERK 1/2 on the conserved TEY motif in their activation loops. Ras is extremely 
efficient in its activation capacity, as evidenced by the fact that 5% Ras activation 
leads to complete ERK 1/2 activation (82). ERK 1/2 targets cytoplasmic proteins, 
membrane proteins, cytoskeletal proteins and nuclear proteins (83). Rsk 1-3,
Mnki and Mnk2 are subset targets of ERK 1/2 and have been implicated in the 
promotion of protein synthesis (84-86). In addition to enhancing gene expression 
by intermediary kinases, ERK 1/2 can also directly phosphorylate transcription 
factors such as Elk-1, cFos and c-Jun, therefore increasing transcription of pro- 
proliferative genes (87-89). ERK 1/2 can also phosphorylate membrane protein 
substrates phospholipase A2 (PLA2) and epidermal growth factor (90, 91). 
Differential utilisation of these pathways by the ERK module is implicated in many 
diverse downstream cellular responses Including proliferation, survival and 
apoptosis.
1.5.2 PI3 Kinase pathway
PI3K phosphorylates inositol phospholipids on the 3 position of the inositol ring, 
resulting In the production of phospholipids that are present at very low levels prior 
to receptor engagement (92-94). PI-(4,5)-P2, the major substrate of PI3K, is 
phosphorylated to produce PI-(3,4,5)-P3, both of these molecules can act as 
second messengers by acting as ligands for pleckstrin homology (PH) domains 
found in a large number of cytosolic proteins. This enables the co-localisation of 
the PH domain containing proteins as well as recruitment to the plasma 
membrane. PI3K also produces the phospholnsitides PI-(3)-P and PI-(3,4)-P2 
which along with Pl(3,4,5)-P3 are known to govern events such as cell survival, cell 
growth, cytoskeletal remodelling and the trafficking of intracellular organelles (95).
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AKT (PKB) is a major downstream target of the PI3K pathway that can modulate 
cell fate decisions such as survival and proliferation. The AKT protein family 
consists of three isoforms AKT1, AKT2 and AKT3 that are all regulated by similar 
PI3K and phosphorylation dependent mechanisms. AKT contains a PH domain 
that act to recruit AKT to the plasma membrane where it undergoes dimérisation 
and consequently a conformational change, allowing AKT to be phosphorylated by 
serine/threonine kinases such as PDK1 (96). Once AKT has been phosphorylated, 
it translocates to the specific cellular locations where it has multiple pro-survival 
actions targeting both mitochondrial and caspase-dependent events (97).
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1.6 Aims and objectives
The initial aim of this study was to investigate the role of Ras and how its activity 
impacted the biological outcome of |3 selection, utilising a number of T cell 
generating culture systems. Upon emergence of sustained B220* cells within 
these T cell environments we then went on to investigate the mechanisms that may 
account for this phenomenon. We are interested in expanding the knowledge 
gained in these studies and addressing how modulators of Ras activity can impact 
the biological outcomes of [3 selection and B/T cell lineage decisions.
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Figure 1.1 Schematic diagram of Notch signalling. Notch ligands (Jagged/DL) 
are expressed by stromal cells and bind to Notch receptors on the HPCs. This 
induces the presenilin-dependenty-secretase-mediated cleavage of intracellular 
Notch (ICN) (98). ICN translocates to the nucleus, where it interacts with a 
transcriptional co-activator (CoA), which in turn displaces a co-receptor complex 
(CoR) containing silencing mediator of retinoid and thyroid hormone receptors 
(SMR) and histone deacetylase (HDAC1) from its association with the DNA-binding 
protein CSL (CBF1/RBF-J), to induce the transcription activation of T-cell-lineage- 
specific genes. Diagram taken from Nature Reviews: Immunology 2004, T - cell 
development made simple’ by J.C. Zuniga-Pflucker (99).
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Figure 1.2 Schematic diagram of intrathymic T-ceii development. The thymic 
architecture is organised into discrete cortical and medullary areas, each of which 
is characterised by the presence of particular stromal cell types, as well as 
thymocytes precursors at defined maturation stages (100). Interactions between 
Notch receptor-expressing thymocytes and thymus stromal cells that express 
Notch ligands induce a complex programme of T-cell maturation in the thymus, 
which ultimately results in the generation of self-tolerant CD4* helper T cells and 
CD8* cytotoxic T cells. Diagram taken from Nature Reviews: Immunology 2001, 
‘Lymphostromal interactions in thymic development and function’ by Anderson and 
Jenkinson (20).
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Figure 1.3 Primary checkpoints in T celi development. Thymocyte 
development is characterised by the cell surface expression of CD4 and CD8. DN 
HPCs entering the thymus from the FL or BM have to pass through the primary 
checkpoint (p selection), ensuring that only thymocytes that have generated a 
functionally rearranged TORp chain can be selected to differential to the DP stage. 
The second checkpoint occurs when DP thymocytes undergo positive and negative 
selection, allowing for the differentiation of MHO-restricted and self-tolerant CD4* 
or CD8^ ap-T cells (101).
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Figure 1.4 Signalling downstream of the pre-TCR. The CDS components that 
form part of the pre-TCR contain several immunoreceptor tyrosine-based activation 
motifs (ITAMs) within their cytoplasmic domain. Phosphorylation of the ITAMs 
creates docking sites for the SH2-domain containing Syk-family PTKs (protein 
tyrosine kinases), ZAP-70 and Syk. Adaptors, exchange factors and GTPases, 
regulate more distal events in pre-TCR signalling.
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Figure 1.5 Phenotypic characterisation of B cell development. Definition of 
developmental stages of the various B cell types, present throughout B cell 
development. The classification into various stages of B cell development can be 
defined by the absence or presence of specific surface markers. The earliest 
marker that defines B cells committed to the B cell lineage is the CD45R isoform 
B220. B220 is expressed at all stages of B cell development, and levels increase 
during transition from the immature to the mature stage.
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Figure 1.6 Signalling downstream of Ras. Schematic diagram showing some of 
the many signalling pathways downstream of Ras. Ras is activated through G- 
protein coupled receptors, receptor tyrosine kinases, Janus kinase 1 or increases 
in intracellular calcium. Ras targets multiple effectors.
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CHAPTER 2 -  Materials and Methods
2.1 Animats and Cell Lines
2.1.1 Animals and Primary Cells
Wild type ICR mice were purchased from Harlan-Olac (Oxen, UK) and maintained 
at the University of Glasgow Central Research Facilities. The mice were mated 
overnight and examined for a copulation plug the next morning (day 0 gestation). 
FL cells and foetal thymus (FT) were collected from ICR mice at day 14 of 
gestation.
RAG-T^" mice (37) were bred and maintained in-house. All animals were 
maintained in accordance with local home office regulations. Rag-1 and Rag-2 
genes are responsible for encoding the early lymphocyte-specific proteins 
necessary for initiation of V(D)J recombination (102). inactivation of these genes 
results in a complete lack of functional lymphocytes as a result of a block in 
lymphocyte development at the progenitor B and T cells stages deriving from the 
abrogation of the initiation of V(D)J rearrangement.
2.1.2 Bone Marrow Stromal Cell Lines
OP9 cells are a BM stromal cell line commonly used to investigate the 
differentiation of HPCs into B cell lineage. This cell line does not express 
macrophage colony stimulating factor (M-CSF) which was found to inhibit the 
differentiation of HPCs to blood cells other than macrophages (103). The cell line 
was maintained in 0P9 media (High Glucose-DMEM media containing 10% FBS 
(Bio Whittaker UK Ltd, Wokingham, UK), 100 U/ml penicillin, 100 p.g/ml 
streptomycin, 2 mM glutamine, 1 mM sodium pyruvate, lOmM HEPES, 50 pM 2- 
mercaptoethanol and 10 p,g/ml gentamicin (Invitrogen, Paisley, UK) supplemented 
with 0.5 mg/ml geneticin (Invitrogen).
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0P9-DL1 is a derivative of the 0P9 cell line which has been retrovirally transduced 
to express the Notch-ligand DL1. 0P9-DL1 cells have been shown to lose the 
ability to support B cell development, while gaining the ability to support normal T 
cell development (13). The cell line was maintained in 0P9-DL1 media (a MEM 
containing 100 U/ml penicillin, 100 |j.g/ml streptomycin and 20% FBS (Invitrogen, 
Paisley, UK)). Cells were kept under a humidified atmosphere of 5% CO2 at 37°C, 
and split every four days with media changes every two days.
2.1.3 SL-12p.12 Cells
SL-12(312 cell line is a pre-T cell line derived from a spontaneous SCID mouse 
thymoma, that stably expresses functionally-rearranged TCR-p chain at the cell 
surface with endogenous pTa to form the pre-TCR (Figure 2.1) (104). The cell line 
was maintained in 0P9 media supplemented with 0.5mg/ml G418/geneticin, and 
kept under a humidified atmosphere of 5% CO2 at 37°C.
2.1.4 Retroviral packaging cell lines.
Retroviral constructs were engineered by subcloning the gene of interest (Ras^^^, 
Ras^^^S35, Ras^^^C40; gifts from Prof. J. Downward) into the retroviral backbone 
(MIEV), 5’ of the internal-ribosomal entry site, allowing the bicistronic expression of 
the gene of interest and green fluorescent protein (GFP). The retroviral vectors 
were stably expressed in the retroviral packaging line, GP+E.86 (105) and 
maintained in 0P9 media.
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2.2 Retroviral Infection
2.2.1 Mitomycin C treatment of packaging cell lines
The GP+E.86 cell lines were seeded at 2x10^ cells/well and cultured in 0P9 media 
supplemented with 10 pg/ml mitomycin C (Sigma-Aidrich Co., Poole, UK) for 2-3 
hours at 37°C one day prior to retroviral infection of primary cells. The GP+E.86 
cells were washed three times with OP9 media prior to co-culture with HPCs.
2.2.2 Preparation of HPCs-enriched from FLs
Single cell suspension was prepared from ICR FL by crushing the tissue with a 
glass bottle stopper and passing through 70pm mesh to remove cell debris. HPC- 
enriched-FL cells were obtained by carrying out a CD24 (Heat stable antigen 
(HSA) (BD Biosciences, Oxford, UK)-antibody complement-mediated cell lysis on 
the FL single cell suspension for 30 min at 37°C, as described previously (106). 
The red/dead ceils were removed by density configuration over Lymphocyte- 
Mammal (VH Bio Ltd. Newcastle, UK) at 600g for 15 min at room temperature(RT). 
The enriched population was removed from the interface between the media and 
Lymphocyte-Mammal, and washed in foetal thymic organ culture (FTOC) media 
(0P9 media supplemented with 5% FBS).
2.2.3 Retroviral Infection of HPC enriched population
The HPC enriched population was co-cultured with the mitomycin C-treated 
retroviral packaging line in FTOC media supplemented with 5 pg/ml polybrene 
(Sigma-Aldrich) and 10 ng/ml cytokines (rlL-6, rlL-7 and stem cell factor (SCF) 
Table 2.2) for 24 hr prior to co-culture on the BM stromal cell lines OP9/OP9-DL1 
or in FTOC to assess their ability to give rise to B/T lineage cells.
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2.3 Generation of lymphoid lineage cells from HPCs
2.3.1 FTOC
In order to analyse the T cell developmental potential, retrovi rally-infected HPCs 
were cultured with alymphoid deoxyguanosine (dGuo)-treated FTs. DGuo-treated 
FTs were generated by incubating d14 FTs with 1.1 mM dGuo for 5 days in FTOC 
configuration (FT are placed on a nucleopore filter (Merck Ltd.) at the air-liquid 
interphase in a humidified incubator, 5% CO2 at 37“C) (107) (Figure 2.2). After 5 
days in culture the dGuo was removed from the medium and the cells were 
cultured for a maximum of 2 days prior to reconstitution with retrovirally-infected 
HPCs. dGuo-treated FTs were seeded with 1x10^ retrovirally-infected HPCs in 
Terisaki plates (Fisher Scientific, Loughborough, UK) and incubated in hanging 
drop for 24 hr then placed in FTOC for 7-10 days (media was changed every 4-5 
days) and analysed by flow cytometry.
2.3.2 High Oxygen Submersion (HOS)
In FTOC media d14 ICR FTs were placed into 96 well plates (2 lobes per well), 
pre-seeded with mitomycin C treated retroviral packaging cells lines. The 96 well 
plate was placed into a plastic bag, the air was saturated with 70% 02/5%
0 0 2 /2 5 % N2 and sealed. After 36 hr incubation the FTs were transferred onto 
FTOC and cultured in FTOC media for 7-11 days.
2.3.3 OP9-DL1 co-culture
Transduced HPC-enriched-FL cells were cultured on 0P9-DL1 cells at a density of 
2x10"^ cells/well in the presence of 0P9-DL1 media containing 10 ng/ml of mouse 
IL-7 and Fit-3 ligand (Table 2.2). Media was replenished every two days. Cell 
commitment and developmental progression was assessed by flow cytometry 
during the course of the culture.
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2.3.4 Intraperitoneai Injection of retrovi ral I y infected HPCs
Retrovirally infected ICR HPC-enriched-FL cells were removed from the GP+E.86 
co-culture by gentle pipetting and the cell concentration was adjusted to 1 x 10® 
cells/100 jj-l in sterile PBS for intraperitoneai (IP) transfer to neonatal recipient 
RAG'^' mice. Cells were injected in 100 jrl volumes using an insulin syringe (23- 
gauge needle) at least 3 mice per group as indicated in figure legends. After 6-8 
weeks, the mice were sacrificed and the development of lymphoid cell populations 
was determined by flow cytometry from the spleen and thymus.
2.4 Flow Cytometry
R-phycoerthrin (PE)-, allophycocyanin (APC)-, fluorescein isothiocyanate (FITC) 
and biotin-conjugated anti-mouse antibodies were used for flow cytometric analysis 
(BD Biosciences, Table 2.1). Cells were prepared for flow cytometric analysis as 
described in section 2.2.2 (106). Briefly, the retrovirally-infected HPC-enriched 
cells were either removed from the OP9 or 0P9-DL1 cell lines by gentle pipetting, 
single cell suspensions were generated by crushing the FTOCs or organs and 
resultant cells were washed in FACS buffer (HBSS containing 1% BSA and 0.1% 
sodium azide (Invitrogen)). Cells were incubated with the appropriate antibodies 
(diluted 1:300), as indicated in the figure legends, for 30 min at 4^ ’C. The cells 
were then washed twice in FACS buffer and resuspended in FACS buffer. The 
cells were acquired using a FACSCalibur flow cytometer using the CELLQuest 
software package (BD Biosciences) and analysed using FlowJo (Treestar,
Stanford, CA). All data shown are live gated by size and lack of propidium iodide 
(PI) uptake.
2.5 Semi-Quantitative RT-PCR
Total RNA was isolated from retrovirally infected ICR FL derived HPCs co-cultured 
on 0P9-DL1 cells at days 0 and day 6, using RNAeasy mini kit (Qiagen Ltd., 
Crawley, West Sussex, UK.) following the manufacturers instructions, in order to
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amplify RNA, the RNA substrate needs to be converted into DNA this can be 
achieved through the use of the reverse transcriptase AMV RT (avian myeiobiastis 
virus reverse transcriptase). The AMV synthesizes the new cDNA strand at sites 
determined by the primers used. The resulting cDNA can then be used as a 
template for PCR. Therefore, cDNA from each sample was prepared from 1pig 
RNA using the first strand cDNA synthesis kit (Roche Diagnostic Systems, Lewes, 
UK) following the manufacturers instructions.
Semi-quantitative PCR was performed using the same serially diluted cDNA 
batches shown for (3-actin (13, 108). Samples were amplified by PCR, utilizing 
gene specific primer pairs (Table 2.3), Taq polymerase (Helena Biosciences, 
Fermentas, UK), dNTPs and magnesium sulphate buffer (Roche Diagnostic 
Systems), on an Eppendorf Personal Mastercycler (Eppendorf UK Ltd.,
Cambridge, UK). To separate the PCR products they were pulled down 1 % 
agarose gels/1 x TAE (0.04 M Tris, 0.001 M EDTA-Nag-salt and 0.02 M Acetic 
acid), and vDisualized using ethidium bromide staining and UV imager (Gene 
genius Bio imaging system, Syngene (Synoptics)). Ail PCR products correspond 
to the expected molecular sizes.
2.6 Transfection of SL-12(3.12 cells
All electroporations were carried out using a BioRad Gene Puiser II (BioRad,
Hemel Hempstead, UK). SL-12p.12 cells were electroporated at 960|rF, 260 V, 
attaining a time constant of 50-55 ^sec. Up to 3x10^ cells were transfected with 
desired plasmid DNA (up to 40p.g), as indicated in the figure legends. Each sample 
was transfected with PathDectect reporter plasmids (Stratagene, Amsterdam, NL); 
as indicated in figure legends) and 2|ig plasmid encoding p-galactosidase (pCMV- 
p-gai). The addition of a fixed amount of p-galactosidase plasmid allowed for the 
control of transfection efficiency during the experiment. The p-galactosidase 
activity was used to index the luciferase signai detected, as we were able to assay 
for luciferase and p-galactosidase activity within the same sample (see below and
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(41)). Cells were washed in electroporation media (RPMI 1640 containing 20% 
PCS) and resuspended in 250 pi electroporation media per transfection. DNA and 
cells were combined in 4 mm sterile cuvettes (BioRad) and incubated on ice for 
10min. Transfected cells were put into fresh complete media and incubated for 24 
h at 37°C, with or without the addition of exogenous stimuli or pharmacological 
inhibitors, as indicated in the figure legends. The cells were then lysed and 
analysed for luciferase and p-galactosidase activity.
2.6.1 Reporter plasmid system
This system allows us to determine which upstream kinases are affecting Elk 
activity downstream of the pre-TCR complex ligation within SL-12p.12 cells. The 
reporter system utilizes two plasmids: a fusion-activator plasmid (pFA-Elk), which 
encodes for the trans-activation domain of Elk, fused with the DNA-binding domain 
of GAL4; and a luciferase-reporter plasmid (pFR-Luc), which encodes for the 
luciferase gene under the control of five GAL4 binding elements. Hence, in 
transfected cells, phosphorylation of the Elk-fusion protein by upstream kinases 
can be readout in the form of luciferase activity (Figure 2.3).
2.6.2 Luciferase and (3-galactosidase Assay
SL-12(3.12 cells transfected with the PathDetect reporter plasmids (Stratagene) 
were assayed for luciferase and (3-galactosidase activities utilizing substrates that 
generate light emission. The cells were lysed in lysis buffer (40 mM tricine, pH 7.8, 
50 mM NaCI, 2 mM EDTA, 1 mM MgSO^, 5 mM dithiothretol (DTT), and 1% Triton 
X-100). Supernatant (25 pi) was combined with an equal volume of luciferase 
reaction buffer (30 mM tricine, pH 7.8, 3 mM ATP, 15 mM MgS0 4 , ImM coenzyme 
A, and 10 mM DTT), and after addition of 1 mM luciferin (BD Biosciences), the 
samples were immediately assayed for luciferase activity with a Lumat LB 9507 
Lumlnometer (Berthold Technologies, Bad Wildbad, Germany). To assay for (3- 
galactoside activity, Galacton-Star (substrate for p-galactosidase; Applied
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Biosystems, Bedford, USA) was diluted 1:50 with Galacton-Star Reaction Buffer 
Diluent (Applied Biosystems) and lOOpI was added to each tube after the 
luciferase assay was completed. The tubes were incubated for 30-60 min at RT 
and then the samples were assayed for (3-galactosidase activity, measured as light 
emission with the Lumat LB 9507 Luminometer. Samples were assayed in triplicate 
and the results represent the average luciferase activity indexed for p- 
galactosidase activity.
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Table 2.1 Antibodies used
CD117 PE,APC,FITC 2B8 Rat lgG2bK
CD4 PE.APC RPA.TA Rat lgG2aK
CD8 APC Rat lgG2aK
CD25 PE.FITC PC61.7D4 Rat lgG2bK
TGRp APC,Biotin H57-597
Armenian Hamster 
lgG2k
NK1.1 APC PK135 Mouse lgG2aK
C D IIb PE.FITC Ml/70 Rat lgG2bK
CD19 APC ID3 Rat lgG2aK
CD45R PE.APC.FITC RA3-6B2 Rat lgG2aK
IgM APC IL/41 Rat lgG2aK
CD24 - 30-F1
Antibodies were purchased from BD Pharmingen or Cell Signalling Technologies.
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Table 2.2 Cytokines
Cytokine Species Supplier
rlL-7 Mouse Caltag-MedSystems Ltd.
rlL-6 Mouse Caltag-MedSystems Ltd.
rSCF Mouse Caltag-MedSystems Ltd.
rFlt-3 ligand Mouse R&D Systems
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Table 2.3 Oligonucleotide primers for semi quantitative PCR
bActin F 
bActin R Mouse
5’- GAT GAC GAT ATC GOT GCG CTG -3 ’ 
5’- GTA CGA CCA GAG GCA TAC AGG -3 ’
539
Pax5 F 
Pax5 R Mouse
5’- CTC GGA CCA TCA GGA CAG GAC -3 ' 
5'- TCA TCC CTC TTG CGT TTG TTG -3 ’
All Primers were purchased from MWG-Biotech.
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Figure 2.1 Schematic diagram of the SL-12p.12 ceil line. The SL-12p.12 cell 
line is a pre-T cell line derived from a spontaneous SCID mouse-derived thymoma, 
that stably expresses a functionally rearranged TCRp chain at the cell surface with 
endogenous pTa to form the pre-TCR (106).
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Figure 2.2 In vitro  and in vivo models for studying T lymphocyte 
development. The internal ribosome entry site (1RES) of the bicistronic retroviral 
vector MIEV permits the translation of two open reading frames from one 
messenger RNA, therefore the expression of GFP is directly proportional to the 
level of the gene of interest (Ras^^^, Ras^^^S35 and Ras^’'^C40). HPCs are 
prepared from the FL of d14 RAG/wild type mice and incubated overnight on the 
GP+E.86 retroviral packaging cell line as described in the materials and methods 
(section 2.2.3). The retrovirally infected HPCs are used for FTOC, HOS-FTOC, 
OP9-DL1 co-culture or adoptive transfer assays.
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Figure 2.3 Schematic representation of the Reporter Plasmid System. The
trans-activator plasmid system allows us to determine whether or not our protein of 
interest directly or indirectly activates Elk 1 and therefore Erk-MAPK. The reporter 
plasmid, trans-activator plasmid and expression vector along with our gene of 
interest are cotransfected into the pre-T cell line SL-12p.12. The expression of 
luciferase from the reporter plasmid (pFR-Luc) indicates that our gene of interest is 
directly or indirectly involved in the phosphorylation and activation of the 
transcriptional factor in the trans-activator plasmid, and therefore involved in the 
respective signal transduction pathway.
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CHAPTER 3
3.1 Introduction
3.1.1 Retroviral Infection System
A retroviral vector is an infectious virus used to introduce a non-viral gene into 
mitotic cells in vivo or vitro (109, 110). They originate from replication-competent 
viruses isolated from either rodents or chickens, the vectors are modified to aid the 
transduction process. Retroviral vectors are efficient in achieving stable and 
transient transduction of a gene or genes into cells such as primary cells that are 
not easily transfected by other means, such as electroporation. Retroviral infection 
is dependent on binding to specific cell surface receptors, many of these receptors, 
such as ectotropic and amphotropic receptors are expressed on many cell types 
including most primary cells. As a result it is possible to infect most cells with 
retroviruses.
Although retroviral genomes are made of RNA, they produce a DNA copy of their 
genome immediately after infection of the host ceil by utilizing both retroviral and 
host factors. Mediated by the viral int gene product, the viral DNA integrates into 
the host genome where it is referred to as a provirus. Infectious retroviral stocks 
are made by transfecting the retroviral vector plasmid into cell lines, called 
packaging lines (111). Once in a cell line, transcription proceeds from the viral 
long terminal repeat (LTR) promoter encoded by the plasmid, generating an RNA 
viral genome. The viral genome is then encapsulated by viral structural proteins, 
and the infectious viral particles are produced by budding from the cell surface 
(Figure 3.1).
We utilized the ecotropic packaging cell line GP+E-86 aliowing the infection of rat 
and mouse cells only (112). The GP+E-86 cell line has been generated to express 
gag-pol and env from different plasmids, therefore eliminating the generation of an 
intact retroviral genome. When GP+E-86 cells are co-cultured with the progenitor
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ceils, infectious viral particles containing our Ras mutants are emitted from the 
GP+E-86 cells into the media and thereby infecting our cells of interest. In order to 
determine the role of Ras mediated signalling in T cell lineage commitment, we 
developed the retroviral vector MIEV containing Ras^^^, Ras^^^S35 and Ras^^^C40 
to manipulate HPCs. This vector allows for the transcription of the gene of interest 
plus green fluorescent protein (GFP), thus enabling the retrovi rail y infected cells to 
be identified by flow cytometry via the expression of GFP. The Ras^^^ mutant 
Ras^^^S35 is known to constitutively bind Raf to activate the ERK-MAPK cascade, 
whereas the Ras^^^C40 mutant signals constitutively binds to or activates PI3K, 
and Ras^^^ signals via both .
3.1.2 In vitro generation of T cells
The traditional method of studying T cell development in vitro is the FTOC system, 
which allows T cell development to be studied in isolation and allows for important 
manipulations. FTs can be depleted of endogenous thymocytes by treatment with 
dGuo which allows defined subsets of stem cells or progenitors to reconstitute 
these empty thymic lobes (99, 107, 113). Until recently, efforts to induce T cell 
differentiation in vitro have been unsuccessful in the absence of a thymic 
microenvironment (114). The BM stromal cell line OP9 is derived from the OP'OP" 
mouse, deficient in MCSF, and supports the differentiation of HPCs into B cells 
(115-117), These 0P9 cells were analysed to determine whether they expressed 
Notch ligands, which provide essential cell contact dependent signals required for 
T cell commitment and differentiation (13). The analysis revealed that transcripts 
for Delta-like-1 and Delta-like-4 were undetectable in 0P9 cells, but were present 
in thymus stroma-enriched cell suspensions. Delta-like-1 has been shown to 
engage and induce Notch receptor signalling, therefore it was hypothesised by 
Schmitt et al that lack of Delta-like-1 expression by 0P9 cells may be responsible 
for their inability to support T cell lineage commitment and differentiation. 
Therefore, they generated OP9 cel is expressing high levels of Delta-like-1, OP9- 
DL-1, which proved to be successful in supporting T cell commitment and 
differentiation, while inhibiting the development of B cells in lymphoid progenitor
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cells. HPCs that were induced to differentiate on 0P9-DL-1 cells under went clonal 
expansion and gave rise to both yÔTCR^ (10%) and the CD8’^ TCRa|3^ SP cells 
which were found to be functionally mature (99).
3.2 Results
3.2.1 ERK is activated downstream of the pre-TCR via the Ras/MAPK pathway
To address the question of how ERK is activated downstream of the pre-TCR, we 
chose to utilise the pre-TCR cell line, SL-12pi2. This cell line is commonly used 
as a cellular model which is known to activate ERK downstream of pre-TCR 
ligation (41). We employed a reporter-plasmid system that would allow us to 
determine the involvement of Ras mediated MAPK, and PI3K cascades on ERK 
activation, outlined in the material and methods (section 2.6.1). The addition of a 
fixed amount of p-galactosidase plasmid, to every electroporation, allowed for the 
control of transfection efficiency during the experiment. The p-galactosidase 
activity was used to index the luciferase signal detected, as their activities were 
assayed within the same sample. Hence, in transfected cells, phosphorylation of 
the ELK-1 fusion protein, and therefore ERK-MAPK activity can be read in the form 
of luciferase activity.
Initiaily, we wanted to address what the optimal concentration of our constitutively 
active pcDNAS.Ras^^^ plasmids would be. Therefore, SL-12p12 cells were 
electroporated with pFR-Luc, pCMV-p-gal and pFA-Elk alone, or with 3pg, lOpg or 
30 |ig of the pcDNAS.Ras^^^ plasmid. Cells transfected with pFR-Luc, pGMV-p-gal 
and pFA-ELK alone displayed background luciferase activity (Figure 3.2 (a)). 
Luciferase activity increased about 38.5 fold above background levels in cells 
transfected with pFR-Luc/pCMV-p-gal/pFA-ELK and 3 jig pcDNAS.Ras^^^. This 
increase in luciferase activity fell to 12.6 fold above background luciferase activity 
in cells transfected with 10 jug pcDNAS.Ras^^^, and to below background luciferase
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activity in cells transfected with 30 jig pcDNAS.Ras^^^. Therefore, the optimal 
concentration of the pcDNAS.Ras^^^ plasmid is 3 |ig.
Upon electroporation of SL-12p.12 cells with pFR-Luc/pCMV-p-gal/pFA-ELK and 
stimulation with anti-TCR-p mAh, a 10 fold increase in luciferase activity was 
observed (Figure 3.2 (b)). The luciferase activity noted in unstimulated cells may 
be indicative of low-level constitutive ERK activity within SL-12p.12 cells, as it is 
partially blocked by the addition of the MEK1 inhibitor PD98059 (Figure 3.2 (b))
(41). These data indicate that the engagement of the pre-TCR complex results in 
the activation of ERK and subsequent phosphorylation of the ERK-1/2 substrate,
Elk-1 (41, 118). SL-12p.12 cell were electroporated with pFR-Luc/pCMV-p- 
gal/pFA-ELK/pcDNA3.Ras^^^ and stimulated with anti-TCR-p mAb, which indicated 
a 20 fold increase in luciferase activity in the presence of a constitutively active 
Ras signal (Figure 3.2 (c)). The addition of the MEK1 inhibitor PD98059 results in 
a partial inhibition of luciferase activity, which may imply that other signalling 
molecules and pathways are involved in pElk-1 as well as the MAPK pathway. i
To investigate further the involvement of the MAPK and PI3K pathways in the ERK |
activation downstream of the pre-TCR, we electroporated SL-12pi2 cells with pFR- |
Luc/pCMV-p-gal/pFA-ELK/pcDNA3.Ras^^^S35 or with pFR-Luc/pCMV-p-gal/pFA- |
ELK/pcDNA3.Ras^^^C40 . The transfected cells were then stimulated with |
immobilised anti-TCR-p mAb (Figure 3.2 (c)). Notably, in the cells electroporated i
with pFR-Luc/pCMV-p-gal/pFA-ELK/pcDNA3.Ras^^^C40 the levels of luciferase i
activity were less than that of the pFR-Luc, pCMV-p-gal and pFA-ELK alone cells, 
indicating that the PI3K signalling pathway may not be involved in ERK activation 
downstream of the Ras in SL-12p12 cells.
To investigate the role of Ras-MAPK signalling in ERK activation downstream of 
the pre-TCR complex, we electroporated SL-12p.12 cell with pFR-luc/pCMV-p- 
gal/pFA-ELK/pcDNA3.Ras^^^S35, and stimulated with anti-TCR-p mAb (Figure 3.2 
(c)). These electroporated cells show a 12 fold increase in iuciferase activity when
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unstimulated, and a 24 fold increase in luciferase activity when stimulated. Upon 
addition of PD98059 we observe a 3 fold decrease in luciferase activity in 
unstimulated cells, and a 2.5 fold decrease in luciferase activity in stimulated cells, 
indicating that the MAPK pathway may not be the only signalling mechanism 
involved downstream of the pre-TCR in SL-12p.12 cells in activating Elk-1.
Taken together, these results imply that Ras activates ERK downstream of the pre- 
TCR, in SL-12p.12 cells. However, this does not appear to involve signalling 
through the Ras-mediated PI3K pathway. The MAPK signalling pathway does 
show ERK activation, but only 41% of the activation levels expressed in the 
presence of a constitutively active Ras^^^ signal. Suggesting, that either other 
signalling molecules apart from MEK may be playing a role in ERK activation 
downstream of the pre-TCR complex in SL12-p.12 cells (e.g. PKCs, PDEs, etc.), or 
that it may be the result of a complementary synergistic activation of both signalling 
pathways.
3.2.2 Introduction of Ras^^^ retrovirally infected wild type FL-derived HPCs into 
FTOC results in the production of CD45R^ B cells
Freshly prepared wild type FL cells were retrovirally infected with either vector
alone (MIEV), or with Ras^^^ encoding vector (MIEV.Ras^^^). Retrovirally infected
HPCs (CD1 IT^GFP"^) were separated by flow cytometric cell sorting and placed
into FTOC for 13 days. After this time FTOCs were analysed by flow cytometry for
the ability of Ras^^^ expressing progenitor cells to progress through T cell
development (Figure 3.3). After 13 days incubation, we observed a high
percentage of GFP'*' cells in both the MIEV control (78%) and Ras^^^ (95%)
reconstituted FTOCs. Upon analysis of the GFP'*' population of cells we noted that
the MIEV-FTOC culture had progressed through p selection with an emergence of
DP CD4'*' and CD8“^ thymocytes, with minimal B cell commitment as expected
(Figure 3.3). However, analysis of the Ras^^^-FTOC culture showed that there was
a 32% decrease in DP thymocytes, and a 70% increase in B cell commitment
(Figure 3.3). Thus, indicating that B lymphocytes are being generated in a T cell
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microenvironment in the presence of a constitutively active Ras signal, suggesting 
that there may be an inhibition of T cell lineage commitment.
To investigate this further, freshly prepared FL cells were retrovirally infected with 
vector alone (MIEV), MIEV.Ras''^^ MIEV.Ras''''^S35, or MIEV.Ras'''^C40. The 
retrovirally infected foetal thymic lobes were placed into HOS-FTOC for 8-12 days. 
Although all the samples have GFP populations, they are at lower levels than that 
of the FTOC, this may be due to an inability for retroviral particles to 
penetrate/infuse into FT three dimensional structure. Upon analysis of T cell 
surface markers by flow cytometry, the GFP"*" population of the MIEV culture 
showed the emergence of CD4'‘‘CD8"'“ DP cells at days 8 and 12, as expected 
(Figure 3.4). The Ras^^^C40 HOS-FTOCs also displayed an emergence of 
CD4CD8^ DPs at days 8 and 12 (27% and 46% respectively). However, there was 
a marked decrease in T cell commitment and differentiation seen in the Ras^^^ and 
Ras^^^S35 HOS-FTOCs, in comparison with MIEV control. Ras^^^ culture 
produced 5% DPs at day 8, and 1% DPs at day 12. The Ras^^^S35 culture 
contained 15% DPs at day 8, and 5% DPs at day12 (Figure 3.4). From this, we 
concluded that the constitutive activation of the ERK-MAPK signalling cascade, via 
Raf, in HOS-FTOC is significantly delaying, or inhibiting T cell development.
Figure 3.5 shows the flow cytometric analysis of NK1.1, CD19 and igM lymphoid 
markers present at day 8. The Ras^^^ and Ras^^^S35 HOS-FTOCs displayed an 
increase in CD 19 expression (55% and 28% respectively) compared to MIEV and 
Ras^^^C40 (0% and 3% respectively). In conclusion, HOS-FTOCs reconstituted 
with Ras^^^ and Ras^^^S35 showed a decrease in T cell commitment and an 
increase in B cell expression marker CD 19.
43
3.2.3 Ras^^^-ERK signals compete with Notch
We were interested in using the OP9-DL1 model system to investigate the 
mechanisms invoived in T cell development, so initially we set out to generate 
mature T lymphocytes by co-culturing HPCs on 0P9-DL1 cells. To determine if 
our 0P9-DL1 cells have the ability to support and maintain T cell commitment and 
differentiation, FL-derived HPCs were obtained from wild type mice at day 14 of 
gestation, and co-cultured with the 0P9-DL1 cells, in the presence of IL7 and 
Flt3L. Flow cytometric analysis was carried out at days 4,8, 12 and 16 of the 
cultures. Our results indicated that by day 8 the majority of HPCs had given rise to 
CD117 CD25^ DNIII cells (Figure 3.6 (a)) suggesting commitment to the T cell 
lineage (14, 119). Day 16 culture analysis showed that the 0P9-DL1 cells give rise 
to, and support, DP thymocytes while down regulating CD25 (Figure 3.6 (b)), 
demonstrating our ability to generate T cells by OP9-DL1/HPCs co-culture.
To further investigate the role that constitutively activated Ras plays in T cell 
development, freshly prepared wild type FL cells were retrovirally infected with 
MIEV, MIEV.Ras'^^^ MIEV.Ras'''^S35, or MIEV.Ras''^^C40. The retrovirally 
infected HPCs cells were placed onto 0P9-DL1 cultures for 4-8 days. After this 
time the FL-derived cells were analysed by flow cytometry to determine the ability 
of constitutively active Ras expressing cells to progress through T cell 
development. From figures 3.8 and 3.9 it can be seen that GFP'*' cells were 
evident in all cultures at days 4 and 8. Flow cytometric analysis of the cultures at 
day 4 (Figure 3.7) and day 8 (Figure 3.8), revealed normal T cell commitment and 
development in the uninfected (GFP ) cell populations, as evidenced by the 
presence of CD117^CD25^ DNII and CD117"CD25^ DNIII thymocytes. Overall, at 
day 8 (Figure 3.8), the GFP", GFP'° and GFP^' Ras^^^C40 cultures showed a DNII 
to DNIII shift (66%, 60% and 28% respectively) when compared to the MIEV 
control (18%, 21% and 18% respectively). Further analysis is required to confirm 
whether an increase in advancement through T cell development is evident via 
constitutive PI3K signalling.
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Upon analysis of the GFP’*' cells in Figure 3.9, we observed an increase in B cell 
populations in both the Ras^^^ and Ras^^^S35 cultures, when compared to the 
MIEV alone or Ras^^^C40 cultures. At day 4, the GFP'° and GFP^‘ Ras^^^ cultures 
showed a 9% increase in CD45R expression when compared to the respective 
MIEV cultures. At this time it was noted that the GFP*^ ' Ras^^^S35 culture showed 
a 1.5% increase in CD45R expression when compared to the MIEV control. At day 
8, the Ras^^^ cultures showed a 54% (GFP'°) and 84% (GFP^‘) increase in CD45R 
expression when compared to MIEV (Figure 3.9). The ability of HPCs 
constitutively expressing Ras^^^ to generate B lymphocytes corresponds to our 
HOS FTOC (Figure 3.5). Also at day 8, it can be observed that the Ras^^^S35 
culture showed a 23% (GFP'°), and a 54% (GFP^‘) increase in CD45R expression 
(Figure 3.9) when compared to MIEV. The differences between the GFP'° and 
GFP^' populations appear to be dose dependent, with the greater the expression of 
GFP relating to the greater the expression of the gene of interest (36, 106, 120, 
121). Interestingly, from figures 3.8 and 3.9 we noted that the Ras^^^C40 culture 
contained no B cell commitment at day 4 or day 8.
3.2.4 Retrovirally infected RAG" '^ FL-derived HPCs commit and differentiate when 
cultured on 0P9-DL1 cells
To confirm that the activation of the ERK-MAPK cascade plays a central role in B 
cell lineage commitment, we retrovirally infected freshiy prepared RAG'^‘ FL cells 
with either MIEV alone or containing Ras^^^, Ras^^^S35, or Ras^^^C40. As 
mentioned previously RAG'^' mice are blocked at the p selection stage of 
development and, therefore, are normally unable to develop mature B and T cells 
(38).
The RAG"^ " retrovirally infected HPCs were placed onto OP9-DL1 cultures for 4-8 
days. After this time the FL-derived cells were analysed by flow cytometry for the 
ability of Ras expressing cells to commit to the T cell lineage. Figures 3.10 and 
3.11 show that GFP'*' cells were evident in all cultures at days 4 and 8. Flow 
cytometric analysis of the uninfected (GFP") cell populations at day 4 and day 8,
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revealed normal T cell commitment and development by RAG' '^ mice, as evidenced 
by the presence of DNII and DNIII thymocytes.
At day 8 (Figure 3.11), when we analysed for T cell surface markers we saw a 
decrease in T cell markers in the Ras^^^ and Ras^^^S35 cultures, when compared 
to MIEV and Ras^^^C40. In the MIEV culture we see 41 % (GFP'°) and 36%
(GFP* '^) DNII Is present at day 8, however in the Ras^^^ culture we see 5% (GFP'°) 
and 1.7% (GFP^‘) DNIIIs, and in the Ras^^^S35 culture we observe 6% (GFP'°) and 
4% (GFP* ‘^) DNIIIs. Therefore, in comparison to MIEV, the Ras^^^ shows a 36% 
(GFP'°) and a 34% (GFP* '^) decrease in DNIII thymocytes. Also, the Ras^^^S35 
culture shows a 32% (GFP‘°) and a 32% (GFP^‘) decrease in DNIII thymocytes 
(Figure 3.11).
Upon analysis of the GFP'*' cells in Figure 3.12, we saw an increase in B cell 
populations in both the Ras^^^ and Ras^^^S35 cultures, when compared to the 
MIEV alone or Ras^^^C40 cultures. In comparison to the MIEV culture, at day 4 
the Ras^^^ population showed an 8% (GFP'°) and 1.5% (GFP^‘) increase in CD45R 
expression, and the Ras^^^S35 population showed a 9% (GFP'°) and 15.5% 
(GFP* '^) increase in CD45R expressing cells. At day 8, in comparison to the MIEV 
culture the GFP’° Ras'^^  ^and Ras'^^^S35 populations showed a 15% and 10% 
increase in CD45R expression respectively. Also at day 8, the GFP* '^ Ras^^^ and 
Ras^^^S35 populations showed a 29% and 11% increase in CD45R expression 
respectively. It was noted that the Ras^^^C40 culture contains no B cell 
commitment at day 4 or day 8 (Figure 3.12).
Thus far, the data obtained from the in vitro mouse model systems examined have 
concurred to show the same trend and outcome.
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3.2.5 Ras/ERK-MAPK signalling in HPCs resuits in the development of B cells in 
vivo
As it is important, where possible, to study the development of lymphocytes in a 
normal physiological environment we utilised an adoptive transfer system. In order 
to determine the ability of our wild type derived retrovirally infected HPCs to commit 
to B cell development, within a T cell environment, we adoptively transferred them 
into neonatal RAG'^'mice. A mixture of both GFP" and GFP^ cells were injected 
into the recipient mice, therefore providing a useful internal control of wild type cells 
and allowing a comparison of lymphocyte development within the same host 
mouse.
The ability of the retrovirally infected wild-type donor cells to reconstitute the 
thymus of the host RAG mice was assessed 6-8 weeks post-injection. Figure 
3.13 showed that the RAG T '^ thymus has been reconstituted with the wild type 
HPCs, due to the presence of CD4^CD8^ double positive cells. On comparison it 
was seen that the MIEV control and Ras^^^C40 mice had similar double positive 
populations, 86% and 82% respectively at the GFP'° level. In contrast the 
Ras^^^S35 animal only had 19%, thus supporting the in vitro data shown above.
Analysis of B ceil markers CD45R and IgM showed that the Ras^^^S35 mouse 
contained 26% CD45R'*'lgM'*’ cells in comparison with the MIEV and Ras^^^C40 
animals, 0.1% and 0% respectively, at the GFP* '^ level (Figure 3.13). This showed 
that constitutive activation of the Ras-ERK/MAPK pathway within the in vivo thymic 
environment resulted in the emergence of B cells, which was not seen in the 
control populations. However, constitutive activation of the PI3-K pathway, or lack 
of constitutive activation of ERK/MAPK, resulted in cell populations almost identical 
to the control.
3.2.6 Activation of the Ras/ERK-MAPK signalling cascade promotes the up- 
regulation of Pax5 expression.
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The entry of lymphoid progenitors into the B cell pathway depends on the 
transcription factors E2A, EBF, and Pax5 (16). Pax5 is essential for the 
commitment of early progenitors to B lymphoid lineage, homozygous mutation of 
the Pax5 gene arrests B cell development at the early pro-B cell stage in the bone 
marrow (17). Semi-quantitative PCR analysis of retrovirally infected HPCs co- 
cultured on 0P9-DL1 cells revealed that the constitutive activation of Ras^^^S35, 
induced the expression of Pax5 (Figure 3.14) (16, 17, 45, 58, 122, 123). Pax5 is 
detectable at low levels at dO cultures, this may be due to small percentage of B 
lineage cells present in FL-HPC enriched populations (Figure 3.14). However, we 
observed an increase in expression of Pax5 in our day 6 cultures of Ras^^^S35 
retrovirally infected HPCs. Pax5 was not detectable in the MIEV or Ras^^^C40 
cultures at day 6, as these cultures contained mainly T cell lineage cells. This data 
concurs with the results obtained from the various in vitro systems that we have 
examined throughout the course of this research.
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Figure 3.1 Life cycle of replication competent retrovirus. All retroviruses infect 
the host cel is through an interaction with a specific viral receptor on the host cell 
surface, thereby entering the host cell and initiating reverse transcription of the 
RNA viral genome. The viral transcript contains the packaging sequence \\f which 
is recognised by the capsid proteins and allows it to be packaged into virus 
particles. A fully infectious viral particle containing the vector genome is thus 
budded form the packaging cell.
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Figure 3.2 ERK activation downstream of the pre-TCR via the constitutively 
active pcDNA.Ras mutants, (a) SL-12pi2 cells were electroporated with pFR- 
Luc (5pg), CMV-p-gal (2pg), pFA-Elk (5pg) alone, or with 3^ig, 10jag or SOjug of 
constitutively active pcDNA.Ras^^^. The transfected cells were then cultured for 
16-20 hr, then lysed, and the lysates assayed for luciferase and (3-galactosidase 
activity, (b) SL-12p12 cells were electroporated with pFR-Luc (5|ig), CMV-(3-gal 
(2p.g), pFA-Elk (5iug) atone, or with constitutively active pcDNA.Ras^^^ (3^g). 
These cells were then pre-treated with, or without, the MEK-1 inhibitor PD98059 
(lOp-M) for one hour before being stimulated with, or without, anti-TCRp Ab 
overnight. The transfected cells were then cultured for 16-20 hr, then lysed, and 
the lysates assayed for luciferase and p-galactosidase activity, (c) SL-12pi2 cells 
were electroporated with pFR-Luc (5|^g), CMV-(3-gal (2jj.g), pFA-Elk (Sjug) alone, 
and with constitutively active pcDNA.Ras^^^C40 or pcDNA.Ras^^^S35 (3pg). 
These cells were then pre-treated with, or without, the MEK-1 inhibitor PD98059 
(lOpM) for one hour before being stimulated with, or without, anti-TCR(3 Ab 
overnight. The transfected cells were then cultured for 16-20 hr, then lysed, and 
the lysates assayed for luciferase and (3-galactosidase activity. This data is 
representative of one experiment.
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Figure 3.3 introduction of retrovirally infected wild type FL-derived
HPCs into FTOC results in the production of CD45R* B ceils. FL cells were 
removed from time pregnant wild type mice (day 14 gestation) and retrovirally 
infected with either vector alone (MIEV) or Ras^^^ for 24 hr. GFP^ CD117"^  cells 
were separated by flow cytometric cell sorting and placed in hanging drop with 
dGuo-treated FTs. After 24 hr the FT were incubated in FTOC for 13 days. Flow 
cytometric analysis of CD4 vs. CD8 and IgM vs. CD45R cell surface expression on 
thymocytes gated for GFP expression is shown (R2: GFP" )^.
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Figure 3.4 Analysis of T cell expression markers upon the introduction of 
Ras^^^S35 wild type FL-derived HPCs into NOS FTOC mimic’s the effect of
Ras'^^ .^ FLs were removed from time pregnant wild type mice (day 14 gestation) 
and retrovirally infected as described in section 2.3.2. After 24 hr the FT were 
transferred to FTOC and cultured for 7 to 11 days. Flow cytometric analysis of 
days 8 and 12 CD4 vs. CD8 cell surface expression on thymocytes gated for GFP 
expression is shown (R2: GFP*). This data is representative of three separate 
experiments.
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Figure 3.5 Introducing Ras^^^S35 wild type FL-derived HPCs into NOS FTOC 
mimics the effect of Ras^^^. FLs were removed from time pregnant wild type mice 
(day 14 gestation) and retrovirally infected as described in section 2.3.2. After 24 
hr the FT were transferred to FTOC and cultured for 7 to 11 days. Flow cytometric 
analysis at day 8 of GDI 9 and IgM cell surface expression on thymocytes gated for 
GFP expression is shown (R2; GFP'*'). This data is representative of three separate 
experiments.
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Figure 3.6 Generation of mature T lymphocytes on OP9-DL1 cells. Wild type 
HPCs were prepared (as described in the materials and methods section 2.2.2) 
and placed onto co-culture for 4-16 days with OP9-DL1 cells. At these time points 
flow cytometric analysis for T cell markers (a): CD117, CD8 and GD25, and (b): 
CD8 and CD4 are shown. It has been found that the expression of the Notch 
ligand Delta-Like-1 on the BM stromal cell line 0P9, supports the differentiation of 
HPCs into CD4^CD8'*' immature DP T cells after 7 days of co-culture, and these DP 
T cells accounted for the majority of HPC-derived cells by day 12. HPCs co­
cultured with 0P9-DL1 cells failed to give rise to B cells, while the differentiation of 
NK cells was readily observed throughout (13). This data is representative of four 
separate experiments.
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Figure 3.7 Analysis of T cell expression markers on retrovirally infected wild 
type FL-derived HPCs cultured on OP9-DL1 cells for 4 days. FL cells were 
removed from timed pregnant wild type mice at day14 of gestation and retrovirally 
infected with vector alone (MIEV) or Ras^^^, Ras^^^S35 or Ras^^^C40, for 24 hr. 
After 24 hr the FL cells were incubated on OP9-DL-1 cells for 4 days. Flow 
cytometric analysis of cell markers CD 117 and CD25 is shown at day 4. This data 
is representative of three separate experiments.
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Figure 3.8 Analysis of T cell expression markers on retrovirally infected wild 
type FL-derived HPCs cultured on OP9-DL1 cells for 8 days. FL cells were 
removed from timed pregnant wild type mice at day14 of gestation and retrovirally 
infected with vector alone (MIEV) or Ras^^^, Ras^^^S35 or Ras^^^C40, for 24 hr. 
After 24 hr the FL cells were incubated on 0P9-DL-1 cells for 8 days. Flow 
cytometric analysis of cell markers CD117 and CD25 Is shown at day 8. This data 
is representative of three separate experiments.
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Figure 3.9 Analysis of lymphoid cells surface expression markers on 
retrovirally infected wild type FL-derived HPCs cultured on 0P9-DL1 cells 
mimic FTOC. FL cells were removed from timed pregnant wild type mice at day 
14 of gestation and retrovirally infected with vector alone (MIEV) or Ras^''^, 
Ras^^^S35 or Ras^^^C40, for 24 hr. After 24 hr the FL cells were Incubated on 
0P9-DL-1 cells for either 4 or 8 days. Flow cytometric analysis of cell markers 
NK1.1 and CD45R Is shown at days 4 and 8. This data Is representative of three 
separate experiments.
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Figure 3.10 Retrovirally infected RAG  ^ FL-derived HPCs commit and 
differentiate when cultured on OP9-DL1 cells for 4 days. FL cells were 
removed from timed pregnant RAG' '^ mice (day 14 of gestation) and retrovirally 
infected with (MIEV) or Ras^^^, Ras^^^S35 and Ras^^^C40, for 24 hr. After 24 hr 
the FL cells were incubated on OP9-DL1 cells for 4 days. Day 4 flow cytometric 
analysis for T cell markers GD117 and CD25 are shown. This data is 
representative of three separate experiments.
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Figure 3.11 Retrovirally infected RAG  ^ FL-derived HPCs commit and 
differentiate when cuitured on OP9-DL1 celis for 8 days. FL cells were 
removed from timed pregnant RAG" ‘^ mice (day 14 of gestation) and retrovirally 
Infected with MIEV or Ras^^^, Ras^^^S35 and Ras^^^C40, for 24 hr. After 24 hr the 
FL cells were incubated on OP9-DL1 cells for 8 days. Day 8 flow cytometric 
analysis for T cell markers GD117 and GD25 are shown. This data is 
representative of three separate experiments.
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Figure 3.12 Retrovirally infected RAG  ^ FL-derived HPCs commit and 
differentiate when cultured on OP9-DL1 cells. FL cells were removed from 
timed pregnant RAG‘ “^ mice (day 14 of gestation) and retrovirally infected with 
MIEV or Ras^^^, Ras^^^S35 and Ras^^^C40, for 24 hr. After 24 hr the FL cells were 
incubated on 0P9-DL1 cells for 4 - 8 days. Flow cytometric analysis for cell 
markers NK1.1 and CD45R are shown. This data is representative of three 
separate experiments.
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Figure 3.13 Activation of Ras/ERK-MAPK signalling in HPCs results in the 
reconstitution of thymuses with B cells in vivo. FL cells were removed from 
timed pregnant wild type mice at day14 of gestation and retrovirally infected with 
MIEV or Ras'''^ Ras''^^S35 or Ras''^^C40, for 24 hr. 1 x 10^cells/100^1 of PBS per 
condition were IP injected into RAG''" neonatal mice. Dissecting the mice at week 
8, and obtaining flow cytometric analysis on the cell populations present 
determined organ reconstitution. This data is representative of two separate 
experiments.
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Figure 3.14 Activation of the Ras/ERK-MAPK signalling cascade promotes 
the up-regulation of Pax5 expression. RNA extracts were prepared from MIEV-, 
Ras^^^S35- and Ras^^^C40- retrovlraiiy-infected HPCs that were co-cultured with 
0P9-DL cells for 6 days. Semi-quantitative PGR was performed using the same 
serially diluted cDNA batches shown for p-actin. Pax5 expression levels present in 
each culture is shown. This data is representative of one experiment.
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Chapter 4 -  General Discussion
The thymus plays a major role in the immune system as it is crucially required for T 
cell differentiation and repertoire selection (124). These processes are mediated 
by the thymic stroma, with its complex cellular composition (20). However, the 
unique functions of the thymus reside mainly in the thymic epithelium, the major 
sub-compartment of the stroma. Each of the two regions of the stroma, the cortex 
and medulla, contains several structurally and phenotypically distinct types of 
thymic epithelial cells (TECs), it is widely thought that these TEC subsets generate 
discrete intrathymic environments each specialised for mediating a particular 
aspect of thymocytes development (18, 19, 125-127). The first demonstration of 
the thymuses crucial role in establishing the development of a normal immune 
system was provided in 1961, when it was shown the mice thymectomized 
immediately after birth had poorly developed lymphoid tissues, impaired immune 
responses and increased susceptibility to infections (128). Although many 
molecular factors have been identified, such as extracellular matrix components 
and chemokine receptors and their ligands, the exact mechanisms involved in 
thymocytes differentiation has yet to be completely characterised (129,130). As a 
result of these environmental factors the thymus has a unique ability to support the 
development of T cells from incoming HPCs derived from either FL or BM.
Some answers have been provided by experiments that demonstrate that although 
T and B cells might share a MPC, their developmental processes are different and 
take place in distinct locations (131). Recent studies have shown an important role 
for Notch signalling at various stages of development (132, 133). In particular, 
several lines of evidence have indicated a crucial role for Notch signalling in the T 
versus B cell fate (12, 117, 134, 135).
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4.1 Constitutive Ras^^^S35 signalling interrupts T cell commitment
As a thymic microenvironment is required for T cell commitment and development, 
we utilised the in vitro system most commonly used to study this, the FTOC. In an 
attempt to elucidate the role of Ras signalling in T iymphopoeisis we utilised the 
constitutively active Ras^^^ mutant, along with the MIEV.CMV control plasmid. As 
Ras proteins are critical components of signalling pathways that link the activation 
of the cell surface receptors with transcriptional events leading to the control of 
proliferation, differentiation and apoptosis, we had hypothesised that their may be a 
drive towards positive selection during T cell development (136, 137). Surprisingly, 
the results showed a bias towards B cell commitment in the Ras'^^  ^culture over 
that of T cell commitment. As the Ras^^^ mutant is constitutiveiy signailing through 
Ras mediated pathways we believe that this may be inhibiting the environmental 
stimuli within the FTOC and promoting commitment to B cell lineage.
in an attempt to investigate this emergence of B cell commitment in FTOC when 
the Ras^^^ pathway is constitutively activated, we utilised the constitutively active 
mutants Ras^^^S35 and RasV^^C40. Interestingly, the results showed that in the 
HOS-FTOCs reconstituted with Ras^^^ and Rasv^^S35 infected HPCs, there was a 
bias towards B cell commitment (at days 8 and 12) at the expense of T cell 
commitment. However, in the Ras^^^C40 reconstituted HOS-FTOC we saw a bias 
to T cell commitment and minimal B cell commitment. Therefore, we hypothesis 
that the emergence of B cells in the presence of Ras^^^S35 and not Ras^^^C40 
may indicate that there is an inhibition of T cell lineage commitment and that it is 
occurring through the constitutively active ERK-MAPK pathway.
The ability to differentiate T cells on a simple stromal cell monolayer has helped to 
answer fundamental questions regarding molecular interactions required for the 
generation of T ceils, and also served to create a new system for the study of T cell 
development. The 0P9-DL1 cells are easily propagated and manipulated in 
culture, by comparison to previously used FTOCs. Therefore we utilised this 
system to continue our investigation into the role of Ras during lymphocyte
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development. FL-derived HPCs cultured on 0P9-DL1 cells undergo T cell lineage 
commitment due to the presence of the Notch ligand delta-like-1 (9, 13, 117).
Upon the introduction of FL-derived HPCs retrovirally infected with the Ras^^^ 
mutants into co-culture with 0P9-DL1 cells, we observed similar data to our FTOC 
results. These results may imply that constitutive Ras activation of the ERK-MAPK 
pathway is inhibiting T cell commitment, in particular Notch. Research carried out 
by Berset et al and Sundaram et a! suggested that Ras and Notch may be working 
antagonistically in C.elegans, corroborates our results (138, 139). We do not 
believe that the emergence of B cells within our system is due to an outgrowth of 
committed pre-B cells, as previous experiments carried out by Schmitt et a! have 
shown that HPCs cultured on OP9-DL1 cells resulted in T cell commitment, but 
failed to give rise to B cells (13, 119). The emergence of B cell commitment in the 
HOS-FTOC system, which allows us to retrovirally infect HPCs which have never 
left the thymic environment implies it’s not an pre-B cell outgrowth effect. Also, 
during the preparation of the FL cells we carry out a CD24 kill which will eliminate 
most pre-B cells present in the sample. However, only cell sorting of our HPCs will 
allow us to ensure that there are no pre-B cells present in our HPC cell populations 
upon introduction onto OP9-DL1 cells.
Of particular significance were the results from our in vivo adoptive transfer of 
HPCs, retrovirally infected with the Ras^^^ mutants, into RAG‘ ‘^ mice. This system 
also produced an increase in B cell commitment, at the expense of T cell 
commitment, when constitutively activated through the ERK-MAPK signalling 
pathway. These results are particularly important due to being carried out within 
the in vivo thymic microenvironment, in the presence of structural and functional 
stimuli required for normal thymocyte development. Through the course of this 
research we have demonstrated that in a variety of assay models we observe this 
similar trend.
65
4.2 Notch vs. Pax5
From our data we hypothesise that the generation of B lymphocytes in a T cell 
environment may be due to constitutive Ras-MAPK induced expression of Pax5 
inhibiting Notch 1. it has been demonstrated by Souabni et al that pan- 
haemopoietic Pax5 expression strongly promotes B cell development at the 
expense of T lymphopoiesis (16). They have found that Pax5 interferes with T 
lineage commitment and early thymocyte development by repressing the 
transcription of the T cell specification gene Notch 1. The analysis of RNA extracts 
and protein expression of cells arising from our system have shown that Pax5 
expression is indeed upregulated in the Ras^^^S35 retrovirally transfected HPCs 
grown in co-culture with 0P9-DL1 cells.
It has been reported by Ordentlich et a! (140) that the basic helix-loop-helix 
(bHLH) transcription factor E47 is a downstream target of Notch signalling, and that 
activation of Notch 1 inhibits its transcriptional activity. E47 is one of the alternative 
splicing products of the E2A gene. E2A, HEB and E2-2 genes are considered 
important for B and T cell development, lack of the E2A gene alone is sufficient to 
block early B cell development and the removal of both E2A and HEB are sufficient 
for T cell development arrest (141 ). Since E2A proteins are crucial for the early 
stages of both B and T cell development, it is thought the modulation of E2A 
function could be an effective means of controlling lymphocyte differentiation. Le 
Nie et al (141) have reported that the activation of the Notch signalling pathway 
induces the degradation of E2A proteins in a MAPK-dependent manner. They 
concluded that high levels of p42/p44 MAPK activities were found in the B cell 
cultures they analysed, therefore E2A proteins became readily degraded upon 
signalling through Notch pathways. In contrast the MAPK activities were very low 
in the T ceil cultures they tested, consequently they believe MAPK activity is a 
limiting factor for E2A degradation in T cells in the presence of Notch.
in our system we propose that Pax5 may be inhibiting Notch 1, therefore Notch 1 
inhibition may be causing a reduction in E2A degradation in the B cell committing
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population. Lei Nie et al have also hypothesised that B and T cells may have 
different modes of regulation for MAPKs. This introduces an interesting scenario 
for the emergence of B cell populations in our constitutively activated 
Ras/ERK/MAPK 0P9-DL1 cultures. The proposed differences in the modes of 
regulation of MAPKs by B and T cells may be controlling E2A degradation 
differently in the two cell populations, and therefore be producing favourable 
conditions for B cell commitment.
The results obtained from the pcDNA.Ras^^^C40 electroporation assay, imply that 
signalling through the PI3K pathway may have an inhibitory effect on ERK 
activation in SL-12.pi2 cells. This may relate to the observation of minimal B cell 
commitment in the Ras^^^C40 retrovirally infected HPCs on OP9-DL1 cells, in 
FTOC and In vivo. We suggest that in these systems a decrease in ERK-MAPK 
activity may be one of the limiting factors for B cell commitment in this 
environment. This agrees with Lei Nie et ai who propose that T cells commit in an 
environment containing Notch 1 and perhaps low levels of MAPKs (141).
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4.3 Conclusion and further work
Through this research we have shown that upon constitutive activation of the ERK- 
MAPK pathway by Ras there is B cell commitment in a T celi microenvironment, 
implying that exaggerated Ras/ERK/MAPK activity in HPCs results in the 
production of signalling molecules, such as Pax5, which appear to inhibit T cell 
lineage commitment and promote B cell lineage commitment. Therefore, future 
work would include:
♦ Cell sorting: to sort for distinct subsets of cells i.e. ScaP, CD117^Lin", not 
cells committed to B cell development (pre-B cells).
♦ Cell sorting: to enable protein and transcriptional determination of GFP* cell 
populations, thus cells which are expressing our gene of interest.
♦ Utilising RT-PCR techniques to assess the expression of developmentally 
regulated genes over time, such as Ets proteins, PU.1, Notch 1, Hes1 and 
the E2A family member E47 in GFP* cultures.
♦ Utilising western blot techniques for the identification of signalling molecules 
involved in PI3K, ERK-MAPK and Notch 1 signalling.
♦ Retrovirally introducing the dominant negative Ras mutant Ha-Ras^^^, and 
analysing by flow cytometry for B and T cell surface markers, to determine 
effect of constitutively knocking down Ras.
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